Brief Report: Immune Factors in Autism: A Critical Review

Pervasive developmental disorders represent a group of neurodevelopmental disorders that affect children early in their development. Autistic disorder is the best described of these disorders, yet even this term covers a broad group of clinical presentations. Various immune system abnormalities, including autoimmunity and defects in different subsets of immune cells, have been reported in children with autistic disorder, suggesting that immune factors may play a role in the development of autism. Based on anecdotal observation, vaccination was proposed to cause autism in some children, but several controlled studies have failed to support this claim. Intravenous immunoglobulin infusions has been tested as immunotherapy for autism, although the preliminary results are inconclusive and there is a risk of potentially fatal transmission of blood-borne pathogens. To examine this issue, intensive well-controlled epidemiological and bench studies need to be carried out in defined and carefully controlled study subjects to establish the cellular and molecular basis of autism, against which the effects of each proposed immune factor can be examined.

[1]  Sudhir Gupta,et al.  Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics , 1996, Journal of autism and developmental disorders.

[2]  A. Dunn,et al.  Effects of Cytokines on Cerebral Neurotransmission , 1999 .

[3]  M. Goto,et al.  Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis. , 1981, Arthritis and rheumatism.

[4]  V. Singh,et al.  Immunogenetic studies in autism and related disorders , 1996, Molecular and chemical neuropathology.

[5]  S. Deb,et al.  Neuroimaging in autism , 1998, British Journal of Psychiatry.

[6]  Sudhir Gupta,et al.  Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism , 1998, Journal of Neuroimmunology.

[7]  M. Monestier,et al.  Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. , 1999, Environmental health perspectives.

[8]  R. Warren,et al.  Immune abnormalities in patients with autism , 1986, Journal of autism and developmental disorders.

[9]  V. Singh,et al.  Elevated serotonin levels in autism: association with the major histocompatibility complex. , 1996, Neuropsychobiology.

[10]  M. Ernst,et al.  Functional neuroimaging of autistic disorders. , 2000, Mental retardation and developmental disabilities research reviews.

[11]  T. Binstock Intra-monocyte pathogens delineate autism subgroups. , 2001, Medical hypotheses.

[12]  A. Pestronk,et al.  Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. , 1999, The Journal of pediatrics.

[13]  V. Strand,et al.  Biologic agents in the treatment of rheumatoid arthritis. , 2000, Current pharmaceutical biotechnology.

[14]  E. J. Field,et al.  Lymphocyte Sensitization to Basic Protein of Brain in Malignant Neoplasia: Experiments with Serotonin and Related Compounds , 1971, Nature.

[15]  A Anthony,et al.  Enterocolitis in children with developmental disorders , 2000, American Journal of Gastroenterology.

[16]  U. Johansson,et al.  The Genotype Determines the B Cell Response in Mercury–Treated Mice , 1998, International Archives of Allergy and Immunology.

[17]  Lalit,et al.  Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. , 1999, Journal of psychiatry & neuroscience : JPN.

[18]  A. Billiau,et al.  Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-gamma in autoimmune disease models. , 2001, Trends in immunology.

[19]  M. Davies,et al.  Treatment of systemic vasculitis with pooled intravenous immunoglobulin , 1991, The Lancet.

[20]  M. Monestier,et al.  Murine mercury-induced autoimmunity , 1999, Immunologic research.

[21]  J. Stephenson,et al.  Evidence of persistent measles virus infection in Crohn's disease , 1993, Journal of medical virology.

[22]  Y. Shoenfeld,et al.  Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? , 2000, Journal of autoimmunity.

[23]  E. Fombonne,et al.  A case-control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology , 2001, BMC public health.

[24]  D. Grob,et al.  Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. , 1988, The American journal of the medical sciences.

[25]  P. Leinikki,et al.  No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study , 1998, The Lancet.

[26]  Ruth A. Carper,et al.  Inverse correlation between frontal lobe and cerebellum sizes in children with autism. , 2000, Brain : a journal of neurology.

[27]  N. Minshew,et al.  Brain Volume in Autism , 2001, Journal of child neurology.

[28]  U. Krawinkel,et al.  Correlation between chlamydial infection and autoimmune response: molecular mimicry between RNA polymerase major σ subunit from Chlamydia trachomatis and human L7 , 1998, European journal of immunology.

[29]  M. Coleman,et al.  Immunodiagnosis and Immunotherapy in Autistic Children a , 1988 .

[30]  V. Singh,et al.  Antibodies to Myelin Basic Protein in Children with Autistic Behavior , 1993, Brain, Behavior, and Immunity.

[31]  V. Singh,et al.  Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. , 1990, Immunological investigations.

[32]  Paul Law,et al.  Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism , 1999, Journal of child neurology.

[33]  Jun Li,et al.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association , 1999, The Lancet.

[34]  R. Pounder,et al.  Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction , 1998, Journal of medical virology.

[35]  U. Lindh,et al.  Activation of the Immune System and Systemic Immune-Complex Deposits in Brown Norway Rats with Dental Amalgam Restorations , 1998, Journal of dental research.

[36]  M. Bigham,et al.  Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism? , 2001, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[37]  V. Singh,et al.  Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. , 1998, Clinical immunology and immunopathology.

[38]  Y. Shoenfeld Idiotypic induction of autoimmunity: a new aspect of the idiotypic network , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  A. Torres,et al.  Strong association of the third hypervariable region of HLA-DRβ1 with autism , 1996, Journal of Neuroimmunology.

[40]  E. Hollander,et al.  Brief Report: A Pilot Open Clinical Trial of Intravenous Immunoglobulin in Childhood Autism , 1999, Journal of autism and developmental disorders.

[41]  C Bona,et al.  Defining criteria for autoimmune diseases (Witebsky's postulates revisited) , 1993, Immunology today.

[42]  A. Wakefield,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. , 1998, Lancet.

[43]  M. Hirokawa,et al.  The immunoregulatory effects of NK cells: the role of TGF-beta and implications for autoimmunity. , 1997, Immunology today.

[44]  K. Akashi,et al.  Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins. , 1990, The Journal of rheumatology.

[45]  G. Möller,et al.  Mercury-induced renal immune complex deposits in young (NZB x NZW)F1 mice: characterization of antibodies/autoantibodies , 1997 .

[46]  I. Mackay,et al.  Autoimmunity : Thoughts for the millenium , 2000 .

[47]  A. Vandenbark,et al.  Depressed lymphocyte responsiveness in autistic children , 1977, Journal of autism and childhood schizophrenia.

[48]  Y. Shoenfeld,et al.  Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. , 1992, Clinical and experimental rheumatology.

[49]  R. Warren,et al.  Reduced natural killer cell activity in autism. , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.

[50]  B. Diamond,et al.  Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus , 1999, European journal of immunology.

[51]  A. Mäkipernaa,et al.  Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients , 1993, Acta paediatrica.

[52]  E. G. Stubbs,et al.  Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination , 1976, Journal of autism and childhood schizophrenia.

[53]  B. King,et al.  Hyperserotoninemia and antiserotonin antibodies in autism and other disorders , 1992, Journal of autism and developmental disorders.

[54]  P. Tudela,et al.  Systemic lupus erythematosus and vaccination against hepatitis B. , 1992, Nephron.

[55]  A. Plioplys,et al.  Anti-CNS Antibodies in Childhood Neurologic Diseases , 1989, Neuropediatrics.

[56]  Y. Shoenfeld,et al.  A study of 20 SLE patients with intravenous immunoglobulin clinical and serologic response , 1999, Lupus.

[57]  Vijendra K. Singh,et al.  Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation , 1997, Biological Psychiatry.

[58]  Courtney A. Harper,et al.  A genomic screen of autism: evidence for a multilocus etiology. , 1999, American journal of human genetics.

[59]  G. Möller,et al.  Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low‐responders and a shift of the interleukin profile , 1997, Immunology.

[60]  R. Todd,et al.  Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[61]  E. Ross,et al.  MMR vaccination and autism 1998 , 1998, BMJ.

[62]  A. Parke The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses. , 1992, Clinical reviews in allergy.

[63]  B. Leventhal,et al.  Receptor inhibition by immunoglobulins: Specific inhibition by autistic children, their relatives, and control subjects , 1993, Journal of autism and developmental disorders.

[64]  N. Ilbäck Effects of methyl mercury exposure on spleen and blood natural killer (NK) cell activity in the mouse. , 1991, Toxicology.

[65]  M. Delong,et al.  Stereotactic pallidotomy in the treatment of Parkinson disease: an expert opinion. , 1999, Archives of neurology.

[66]  C. Combe,et al.  Arthritis after hepatitis B vaccination. Report of three cases. , 1995, Scandinavian journal of rheumatology.

[67]  A. Dunn,et al.  Mouse Tumor Necrosis Factor-α Increases Brain Tryptophan Concentrations and Norepinephrine Metabolism While Activating the HPA Axis in Mice , 1999, Neuroimmunomodulation.

[68]  Y. Shoenfeld,et al.  Vaccine-induced autoimmunity. , 1996, Journal of autoimmunity.

[69]  Takayuki Mōri,et al.  Detection and Sequencing of Measles Virus from Peripheral Mononuclear Cells from Patients with Inflammatory Bowel Disease and Autism , 2000, Digestive Diseases and Sciences.

[70]  E. Silverman,et al.  Lymphocyte function in autism and Rett syndrome. , 1994, Neuropsychobiology.

[71]  R. Burger,et al.  DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein. , 1995, Neuropsychobiology.

[72]  A. Plioplys,et al.  Intravenous Immunoglobulin Treatment of Children With Autism , 1998, Journal of child neurology.

[73]  H Jick,et al.  Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis , 2001, BMJ : British Medical Journal.

[74]  M. Goto,et al.  Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody. , 1980, Arthritis and rheumatism.

[75]  R. Gale,et al.  Clinical uses of intravenous immunoglobulins. , 1988, Seminars in hematology.

[76]  Andrew J Wakefield MMR vaccination and autism , 1999, The Lancet.